Intralesional acyclovir in the treatment of cutaneous warts: A novel therapeutic approach

Authors

  • Bhargavi Mayakuntla Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
  • Susmitha Meda Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
  • S.S. Ravi Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
  • B Indira Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
  • V Anitha Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
  • V.V.V. Satyanarayana Department of Dermatology, Venereology and Leprosy, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.

DOI:

https://doi.org/10.66344/jpad.v33i2.2151

Abstract

Background  Warts are the cutaneous manifestations of human papilloma virus infection. Although warts resolve spontaneously, many patients seek treatment as they can be painful and may have psychosocial impact in case of multiple cutaneous warts. Acyclovir is an antiviral medication with established efficacy against DNA viruses, could become a possible revolutionary therapeutic option for warts.

 

Objective The purpose of this therapeutic approach is to determine the effectiveness of intralesional injection of acyclovir in the management of cutaneous warts.

 

Methods A total of 18 patients with warts attending DVL outpatient department were selected for the study. Depending on the size of the lesion, the patients received 0.1ml-0.3ml of intralesional acyclovir diluted with distilled water (70mg/ml) in each lesion. The procedure was repeated every two weeks till complete clearance or upto a total of four sessions. Adverse effects were documented, and the study participants were monitored on a monthly basis for three months following the final injection to look for any relapse.

 

Results  All 18 patients completed the study by 8weeks duration. Complete clearance was observed in 9 patients (50%), with an excellent response in 5 patients (27.7%), good response in two patients (11.11%), and no response in 2 patients (11.11%).

 

Conclusion  Intralesional acyclovir can be an efficient therapeutic tool for solitary cutaneous warts, but it provides no added benefit for distant warts. It can be beneficial modality in patients seeking for quick response.

References

1. Elsayed A, Nassar A, Marei A, Hoseiny HAM, Alakad R. Intralesional Acyclovir: A Potential Therapeutic Option for Cutaneous Warts. J Cut Med Surg. 2022;26(1):25-30.

2. Bagwell A, Loy A, McFarland MS, Tessmer-Neubauer A. Oral acyclovir in the treatment of Verruca. J Drugs Dermatol. 2016;15(2):237-8.

3. Bauer DJ. Treatment of plantar warts with acyclovir. Am J Med.1982;73(1A):313-4. doi:10.1016/0002-9343(82)90114-0

4. Phelps WC, Alexander KA. Antiviral therapy for human papillomaviruses: rational and prospects. Ann Intern Med.1995;123(5):368-82.

doi:10.7326/0003-4819-123-5-1995 09010-00008

5. Pechman KJ. Does acyclovir have an adjunctive role in plantar wart therapy? Cleve Clin J Med. 1983;50(2):213.

doi:10.3949/ccjm.50.2.213.

Downloads

Published

02.07.2023

Issue

Section

Original Articles

How to Cite

1.
Intralesional acyclovir in the treatment of cutaneous warts: A novel therapeutic approach. J Pak Assoc Dermatol [Internet]. 2023 Jul. 2 [cited 2026 Aug. 1];33(2):495-8. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2151